PRZOOM - /newswire/ -
Delhi, India, 2009/04/01 - The report analyzes the various segments of the capnography monitoring devices industry and assesses opportunities available for the players. The drivers, trends and challenges for the industry have also been analyzed.
The capnography monitoring devices market, a part of the patient monitoring industry, is characterized as a large under-penetrated market globally. Worldwide, the capnography market is dominated by the US and Europe. However, the emerging countries such as China, India and Russia among others have recently started witnessing a spurt in the demand for quality health services, thereby registering a demand for monitoring devices. Over the past few years, an aging demographic pattern coupled with increasing global pollution and rising cases of obesity have led to a growth in breathing-related illnesses, thereby boosting the growth of this segment. These factors, combined with rising awareness for patient safety are expected to drive the need for capnography devices in the forthcoming years.
Capnography has been commercially available since the past twenty years. However, it was only recently that the device started being used in other critical areas of the hospital as well as in the emergency medical services. Rising patient safety concerns led to the incorporation of new medical standards which drove the demand for these devices. Additionally, clinical studies supporting capnography’s importance in improving patient safety also aided the market's development. Despite the present economic slowdown and lack of education, the market is expected to register growth on account of continuing cost effective innovations, expansion into new market segments and rising health and environment issues.
Geographically, in terms of revenue, the US and European capnography market is growing on the back of favorable demographic factors as well as increasing number of mandates issued by professional medical bodies. The emerging economies offer huge growth potential on account of their large populations, rising per capita incomes and a growing middle-class.
Oridion is regarded as the global leader in the capnography monitoring market, followed by Novametrix/ Respironics and Welch Allyn. Globally, the three major capnography manufacturers account for more than 80% of the total worldwide market. However, in the past four to five years, the market has been witnessing increasing consolidation, wherein the OEM clients such as Philips and others are acquiring the OEM manufacturers in order to enhance their market presence.
The report broadly includes the following:
1. Global Patient Monitoring Market
2. Capnography: An Overview
2.1 Introduction to Capnography
2.2 Market Overview
2.3 Markets for Capnography
3. Market Trends
4. Growth Drivers
5. Market Challenges
6. Major Players
6.2 Welch Allyn
6.3 Novametrix (Subsidiary of Respironics/ Philips)
7. Market Forecast
Tables and Figures
Figure 1.1 Global Patient Monitoring Market: Share of Companies: 2007
Figure 1.2 US Patient Monitoring Product Segments, Share (%): 2007
Figure 2.1 Players in the Capnography Market
Figure 2.2 Capnography Market Break-up: OEM/End-user: 2007
Figure 2.3 Deaths due to Surgical/ Medical Mishaps per 100,000 Population: 2004
Figure 4.1 Obesity by Country: 2005
Figure 4.2 Global Obesity Forecast: (2005 ‧ 2015E)
Figure 4.3: Population Aged 55 and Older in the United States
Table 4.1: Trend for over-60 population (In Million)
Figure 4.4: Worldwide Aging Population: Actual & Estimated (1950-2050E)
Figure 4.5: World Carbon Emissions Per Capita: Actual & Estimated (1990-2030E)
Figure 5.1: Percent of Hospitals Reconsidering/ Postponing CAPEX
Figure 5.2: Percent of Hospitals Reporting Moderate to Significant Decline in Admissions and Elective Procedures in Aug ‧ Oct 2008 (relative to projected levels)
Figure 6.1: Oridion ‧ Revenue Growth (2005-2008)
Figure 6.2: Oridion ‧ Growth in Consumables (2002 ‧ 2008)
Figure 7.1: Global Capnography Market Forecast: 2008 - 2011E
Figure 7.2: Global Healthcare Expenditure by Region: 2006
Figure 7.3: Global Healthcare Expenditure: Actual & Estimated (1950 & 2020E).